- Home
- EAF vs AGL Comparison
EAF vs AGL Comparison
Compare EAF & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EAF | AGL |
|---|---|---|
| Founded | 1886 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Managed Health Care |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 429.4M | 422.9M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EAF | AGL |
|---|---|---|
| Price | $6.11 | $0.46 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 14 |
| Target Price | ★ $11.75 | $2.66 |
| AVG Volume (30 Days) | 253.1K | ★ 4.6M |
| Earning Date | 04-24-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $504,134,000.00 | ★ $5,932,576,000.00 |
| Revenue This Year | $4.25 | N/A |
| Revenue Next Year | $12.49 | $5.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.55 | $0.34 |
| 52 Week High | $20.32 | $6.08 |
Technical Indicators
Market Signals| Indicator | EAF | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 38.90 | 39.82 |
| Support Level | $5.90 | $0.34 |
| Resistance Level | $7.47 | $0.73 |
| Average True Range (ATR) | 0.49 | 0.07 |
| MACD | 0.33 | -0.01 |
| Stochastic Oscillator | 53.38 | 11.09 |
Price Performance
Historical ComparisonAbout EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.